Evidence map›Paper›PMID 26762586›Full record

ArticleJournal of translational medicine2016

Role of a polyphenol-enriched preparation on chemoprevention of mammary carcinoma through cancer stem cells and inflammatory pathways modulation.

Tri Vuong, Jean-François Mallet, Maria Ouzounova, Sam Rahbar, Hector Hernandez-Vargas, Zdenko Herceg, Chantal Matar

Open access · goldAbstract read
In one paragraph

Article in Journal of translational medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 60 citations in OpenAlex.

  1. Polyphenol-enriched fraction ofFrontiers in pharmacology · 2026
    Article
  2. Review
  3. Review
  4. Alaska's Flora as a Treatment for Cancer.International journal of biopharmaceutical sciences · 2024
    Article
  5. Review
  6. Article
  7. Blueberry (Foods (Basel, Switzerland) · 2024
    Review
  8. Article
  9. Experimental Studies on the Therapeutic Potential ofPlants (Basel, Switzerland) · 2024
    Review
  10. Decoding potential targets and pharmacologic mechanisms of curcumin in treating non-small cell lung carcinoma via bioinformatics and molecular docking.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2024
    Article
  11. Article
  12. Novel Probiotic BacteriumMicroorganisms · 2023
    Article
  13. Article
  14. Review
  15. Article
  16. Fermented Mangosteen (Cancers · 2022
    Article
  17. Fermentation ofNutrients · 2022
    Article
  18. Article
  19. BioMed research international · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Tri VuongNutritional Sciences Program, Faculty of Health Sciences, University of Ottawa, R2057 Roger Guindon Hall, 451 Smyth Road, Ottawa, ON, K1H 8M5, Canada. vuongptri@yahoo.ca.
Jean-François MalletCellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Canada. jmallet@uottawa.ca.
Maria OuzounovaCancer Center, Georgia Regents University, Augusta, GA, USA. mouzounova@gru.edu.
Sam RahbarNutritional Sciences Program, Faculty of Health Sciences, University of Ottawa, R2057 Roger Guindon Hall, 451 Smyth Road, Ottawa, ON, K1H 8M5, Canada. srahb089@uottawa.ca.
Hector Hernandez-VargasInternational Agency for Research on Cancer, Lyon, France. vargash@iarc.fr.
Zdenko HercegInternational Agency for Research on Cancer, Lyon, France. herceg@iarc.fr.
Chantal MatarNutritional Sciences Program, Faculty of Health Sciences, University of Ottawa, R2057 Roger Guindon Hall, 451 Smyth Road, Ottawa, ON, K1H 8M5, Canada. chantal.matar@uottawa.ca.
University of Ottawa · CACentre International de Recherche sur le Cancer · FRGeorgia Regents Medical Center · US

Funding

CIHRWorld Health Organization 001
6 · The paper itself

Abstract

backgroundNaturally occurring polyphenolic compounds from fruits, particularly from blueberries, have been reported to be significantly involved in cancer chemoprevention and chemotherapy. Biotransformation of blueberry juice by Serratia vaccinii increases its polyphenolic content and endows it with anti-inflammatory properties.

methodsThis study evaluated the effect of a polyphenol-enriched blueberry preparation (PEBP) and its non-fermented counterpart (NBJ), on mammary cancer stem cell (CSC) development in in vitro, in vivo and ex vivo settings. Effects of PEBP on cell proliferation, mobility, invasion, and mammosphere formation were measured in vitro in three cell lines: murine 4T1 and human MCF7 and MDA-MB-231. Ex vivo mammosphere formation, tumor growth and metastasis observations were carried out in a BALB/c mouse model.

resultsOur research revealed that PEBP influence cellular signaling cascades of breast CSCs, regulating the activity of transcription factors and, consequently, inhibiting tumor growth in vivo by decreasing metastasis and controlling PI3K/AKT, MAPK/ERK, and STAT3 pathways, central nodes in CSC inflammatory signaling. PEBP significantly inhibited cell proliferation of 4T1, MCF-7 and MDA-MB-231. In all cell lines, PEBP reduced mammosphere formation, cell mobility and cell migration. In vivo, PEBP significantly reduced tumor development, inhibited the formation of ex vivo mammospheres, and significantly reduced lung metastasis.

conclusionsThis study showed that polyphenol enrichment of a blueberry preparation by fermentation increases its chemopreventive potential by protecting mice against tumor development, inhibiting the formation of cancer stem cells and reducing lung metastasis. Thus, PEBP may represent a novel complementary alternative medicine therapy and a source for novel therapeutic agents against breast cancer.

Indexed as

ChemopreventionAnimalsBlueberry PlantsBreast NeoplasmsCell Line, TumorCell MovementCell ProliferationDisease Models, AnimalFemaleFermentationHumansInflammationMiceMice, Inbred BALB CMitogen-Activated Protein KinasesNeoplasm InvasivenessMitogen-Activated Protein KinasesPlant ExtractsPolyphenols

Identifiers

PMID26762586
PMCPMC4712588
OpenAlexW2235402592

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.